U.S. flag

An official website of the United States government

NM_000314.8(PTEN):c.371G>A (p.Cys124Tyr) AND PTEN hamartoma tumor syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 17, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000471590.5

Allele description [Variation Report for NM_000314.8(PTEN):c.371G>A (p.Cys124Tyr)]

NM_000314.8(PTEN):c.371G>A (p.Cys124Tyr)

Gene:
PTEN:phosphatase and tensin homolog [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q23.31
Genomic location:
Preferred name:
NM_000314.8(PTEN):c.371G>A (p.Cys124Tyr)
HGVS:
  • NC_000010.11:g.87933130G>A
  • NG_007466.2:g.74692G>A
  • NM_000314.8:c.371G>AMANE SELECT
  • NM_001304717.5:c.890G>A
  • NM_001304718.2:c.-380G>A
  • NP_000305.3:p.Cys124Tyr
  • NP_001291646.4:p.Cys297Tyr
  • LRG_311t1:c.371G>A
  • LRG_311:g.74692G>A
  • NC_000010.10:g.89692887G>A
  • NM_000314.4:c.371G>A
Protein change:
C124Y
Links:
dbSNP: rs876660535
NCBI 1000 Genomes Browser:
rs876660535
Molecular consequence:
  • NM_001304718.2:c.-380G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000314.8:c.371G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001304717.5:c.890G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
PTEN hamartoma tumor syndrome (PHTS)
Synonyms:
PTEN Hamartomatous Tumour Syndrome; PTEN-related disorders
Identifiers:
MONDO: MONDO:0017623; MeSH: D006223; MedGen: C1959582

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000541631Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 17, 2023)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Two novel mutations of PTEN gene in Japanese patients with Cowden syndrome.

Sawada T, Okada T, Miwa K, Satoh H, Asano A, Mabuchi H.

Am J Med Genet A. 2004 Jul 1;128A(1):12-4.

PubMed [citation]
PMID:
15211648

Germline cancer predisposition variants and pediatric glioma: a population-based study in California.

Muskens IS, de Smith AJ, Zhang C, Hansen HM, Morimoto L, Metayer C, Ma X, Walsh KM, Wiemels JL.

Neuro Oncol. 2020 Jun 9;22(6):864-874. doi: 10.1093/neuonc/noaa014.

PubMed [citation]
PMID:
31970404
PMCID:
PMC7283023
See all PubMed Citations (10)

Details of each submission

From Invitae, SCV000541631.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 124 of the PTEN protein (p.Cys124Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with anaplastic astrocytoma and/or Cowden syndrome (PMID: 15211648, 31970404). ClinVar contains an entry for this variant (Variation ID: 233631). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is expected to disrupt PTEN function. This variant disrupts the p.Cys124 amino acid residue in PTEN. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10555148, 12938083, 17324556, 20685300, 21194675, 21828076, 25647146). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024